Broadly speaking, healthcare costs and insurance premiums in the United States have risen sharply in recent years, and many experts expect these increases to continue into 2026 and beyond. These rising costs are placing a severe burden on families across the country, especially those under age 65 and those who do not qualify for Medicare or Medicaid.
For 2026, many surveys and insurers project medical-cost inflation in the U.S. at 9.6 percent, only slightly below 2025 levels. For employer-sponsored insurance plans, one survey estimates that per-employee health benefit costs will exceed $18,500 in 2026, up from $17,500 in 2025. Premiums and out-of-pocket costs, including deductibles and copays, are rising faster than general inflation.
For individuals buying insurance on the open market or through the Affordable Care Act marketplaces, commonly known as Obamacare, premiums in 2026 are expected to rise significantly, in some states by tens of percentage points.
Several factors are driving the increase in healthcare costs. Medical inflation continues to push up the price of hospital care, medical services, and new technologies. Prescription drug prices have climbed, particularly for newer specialty and chronic-disease treatments. At the same time, more people are seeking care, including behavioral health services and long-term management of chronic illnesses. Structural issues also play a role, especially the consolidation of healthcare providers, which often gives hospitals and health systems greater pricing power over insurers.
Compared to just a few years ago, healthcare costs and insurance premiums are significantly higher, and the upward trend shows no clear signs of slowing.
Despite these challenges, there are steps and policy proposals that could help bring costs down for more Americans. Expanding and strengthening subsidies and tax credits, particularly for low- and middle-income households, would help offset rising premiums and keep insurance within reach. Enhanced premium tax credits under the Affordable Care Act previously helped millions of people, but their expiration is now adding pressure to already strained household budgets.
More aggressive regulation or negotiation of prescription drug prices and hospital service costs could also make a meaningful difference. High drug prices and hospital charges are among the biggest drivers of healthcare spending, and allowing greater negotiation power, especially for expensive new treatments, could help limit the runaway costs many patients are currently facing.
Greater emphasis on prevention, early intervention, and chronic-disease management could reduce long-term spending. Expanded insurance coverage for preventive care has allowed more people to see doctors earlier rather than waiting until conditions worsen. Investing in preventive care, wellness programs, and behavioral health services would reduce demand for costly emergency and advanced treatments over time.
Increasing transparency and competition among healthcare providers and insurers may further drive down costs. When pricing is clear and accessible, it can discourage unjustifiably high charges and empower patients to make more informed decisions, particularly those with average incomes who struggle to afford care.
Regulating the structure of insurance policies is another important consideration. Limiting excessively high deductibles and requiring coverage for essential treatments can make healthcare costs more predictable. Policies that cap out-of-pocket expenses for chronic conditions would help ensure that frequent doctor visits, medications, and specialist care do not become prohibitively expensive.
Investing in social determinants of health and strengthening community-based care, especially in rural and underserved areas, could also reduce costs over time. In many of these communities, limited access to primary care forces residents to rely on emergency rooms for treatment. Addressing barriers related to access, nutrition, chronic care, and behavioral health is likely to reduce high-cost interventions and improve overall health outcomes.
Expanding subsidies or public coverage will require increased public spending and strong political will. Similarly, stricter regulations and price controls are likely to face resistance from powerful stakeholders, including pharmaceutical companies, hospitals, and insurers. While concerns about innovation and provider behavior must be considered, they should not deter efforts to reform a system that leaves millions struggling to afford care.
At the same time, any effort to reduce costs must preserve the quality of care, as overly aggressive cost-cutting could harm access for vulnerable patients. Meaningful reform will require coordination among federal and state governments, private insurers, and healthcare providers.
Healthcare costs and insurance premiums in the United States have risen substantially since early 2025 and into 2026, pushing many Americans into an affordability crisis. Without action, the trend is likely to continue. However, there are well-documented policy options that, if implemented thoughtfully, could help restore affordability, improve access, and protect those most affected by rising healthcare costs, particularly low-income households and people living with chronic health conditions.
